Science 37

Clinical research site in Culver City, California

As of July 2026, 1 paid clinical trial is recruiting at Science 37 in Culver City, California. Active studies at this site focus on Vascular Ehlers-Danlos Syndrome alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Science 37 (1)

Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome

for Vascular Ehlers-Danlos Syndrome

1 location in Culver City

Sponsor: Acer Therapeutics Inc.

Sex: All·Age: 15 - 64

Code: NCT05432466·Phase 3·Recruiting·Listed Jun 2022

Apply to this trial

More research sites in Culver City

ProScience Research Group (11 trials)
Local Institution - 0024 (2 trials)
Neurocrine Clinical Site (2 trials)
CenExel (1 trial)
LA Glaucoma Group (1 trial)
Local Institution - 0032 (1 trial)
Science 37 Inc (Remote/Home option) (1 trial)
Science 37, Inc. (1 trial)
Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites (1 trial)
Westside Regional Center (1 trial)

Explore more

Paid clinical trials in Culver City, CA · California clinical trials